This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.
Trial results offer hope of a more effective and tolerable treatment option to manage lupus-related kidney disease.
Participating in research can be a rewarding experience, and is essential to improve the quality of life of people with lupus.
The study will examine the medical impact of mindfulness interventions for lupus patients.
A new study suggests that testing positive for lupus anticoagulant antibodies in the first trimester of pregnancy is the strongest predictor of pregnancy loss in women with lupus.
According to lead author, Dr. Ian Bruce, at the University of Manchester, UK, the results are encouraging
A new study points to specific changes companies can make in clinical trials so that, in the future, clearer data can lead us closer to a cure.
A new study looked specifically at rates of hospitalization for serious infections among people with lupus.